ENTITY
Moderna

Moderna (MRNA US)

82
Analysis
Health CareUnited States
Moderna, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
more
18 Jul 2023 08:55

Everest Medicines (1952.HK) - To Take off Again or to Fall Instead?

Great personnel changes had taken place in Everest Medicines. However, peak sales of core products could be significantly lower than expected. So,...

Logo
409 Views
Share
bullishModerna
12 Jul 2023 08:55

Moderna Inc (MRNA US) - What Would Happen After Moderna Enters China?

Moderna's entry into China is beneficial for both sides, which will have profound impact on China's biopharmaceutical industry.Such cooperation...

Logo
308 Views
Share
bearishModerna
10 Jul 2023 19:42

Moderna (MRNA US): Second Product Submission Is Not Big Enough Needle-Mover

Moderna is in process to submit marketing approval in the US for the investigational respiratory syncytial virus vaccine, mRNA-1345. This year, FDA...

Logo
244 Views
Share
bearishBNC Korea
05 May 2023 23:21

BNC Korea (256840 KS): Margin Pressure; Base Business Faces Regulatory Risk; COVID Drug in Doldrum

We remain bearish on BNC Korea due to regulatory overhang on its base business, competitive pressure in BTX industry, and exposure to Russia & CIS...

Logo
484 Views
Share
09 Feb 2023 23:20

Vertex Pharmaceuticals (VRTX US): Mixed 4Q22 Results; Upbeat 2023 Guidance

Vertex reported Q4 result, with in-line revenue and EPS beat consensus by 7%. The company guided for 2023 revenue of $9.55–9.70B (+7–9%), with the...

Logo
392 Views
Share
x